Philip James Wealth Mangement’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.95M Buy
4,295
+8
+0.2% +$8.11K 0.45% 45
2025
Q4
$4.61M Sell
4,287
-199
-4% -$190K 0.53% 42
2025
Q3
$3.42M Buy
4,486
+7
+0.2% +$5.21K 0.4% 53
2025
Q2
$3.49M Sell
4,479
-1,500
-25% -$1.17M 0.45% 48
2025
Q1
$4.94M Sell
5,979
-216
-3% -$180K 0.6% 40
2024
Q4
$4.78M Sell
6,195
-599
-9% -$496K 0.62% 40
2024
Q3
$6.02M Buy
6,794
+6,346
+1,417% +$5.71M 0.74% 32
2024
Q2
$406K Sell
448
-220
-33% -$176K 0.27% 37
2024
Q1
$520K Buy
668
+1
+0.1% +$712 0.37% 33
2023
Q4
$389K Buy
+667
New +$389K 0.3% 41

Other funds holding LLY

Philip James Wealth Mangement's LLY Position: Q1 2026 in Review

Philip James Wealth Mangement increased its Eli Lilly (LLY) stake by 0.19% in Q1 2026, buying an estimated $8.11K and bringing the position to 4,295 shares worth $3.95M. The position accounts for 0.45% of the portfolio, ranked #45.

Philip James Wealth Mangement first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.02M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Philip James Wealth Mangement held 4,295 shares of Eli Lilly worth $3.95M as of Q1 2026.
  • Philip James Wealth Mangement bought 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
  • Eli Lilly made up 0.45% of Philip James Wealth Mangement's portfolio in Q1 2026, its #45 holding.
  • Philip James Wealth Mangement first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Philip James Wealth Mangement's Eli Lilly position peaked at $6.02M in Q3 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Philip James Wealth Mangement's 13F filing for Q1 2026, filed 28 Apr 2026.